A

ACELYRIN Inc
NASDAQ:SLRN

Watchlist Manager
ACELYRIN Inc
NASDAQ:SLRN
Watchlist
Price: 5.16 USD -13.71% Market Closed
Market Cap: 515m USD
Have any thoughts about
ACELYRIN Inc?
Write Note

ACELYRIN Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ACELYRIN Inc
Total Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
ACELYRIN Inc
NASDAQ:SLRN
Total Liabilities
$86.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Liabilities
$137.4B
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
19%
Gilead Sciences Inc
NASDAQ:GILD
Total Liabilities
$36.1B
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Total Liabilities
$83.4B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
6%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Liabilities
$6.6B
CAGR 3-Years
29%
CAGR 5-Years
24%
CAGR 10-Years
18%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Liabilities
$8.1B
CAGR 3-Years
8%
CAGR 5-Years
19%
CAGR 10-Years
21%

See Also

What is ACELYRIN Inc's Total Liabilities?
Total Liabilities
86.4m USD

Based on the financial report for Dec 31, 2023, ACELYRIN Inc's Total Liabilities amounts to 86.4m USD.

What is ACELYRIN Inc's Total Liabilities growth rate?
Total Liabilities CAGR 1Y
230%

Over the last year, the Total Liabilities growth was 230%.

Back to Top